Recurrences in low grade uterine cancer are not common, but they do happen. When you are treated at the Stanford Women’s Cancer Center, you are monitored closely, which allows us to catch recurrences early.
If you have recurring or metastatic cancer (meaning it has spread to other areas), our doctors will often use a combination of therapies. Experts with Stanford’s Tumor Genomics Program have developed a detailed genomic test that can identify the right drugs for your situation. The program’s specialists meet every two weeks to discuss the subtle nuances of your case, taking into account age, gender, family history, and side effects.
Treatment options may include taking part in a clinical trial using new, highly targeted drugs.
The emotional impact of a second diagnosis can be significant. Your quality of life, mood, and ability to cope with the treatment regimen are always priorities for our doctors. Learn more about our support services »